Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
PM Modi said in a recent interview that 'he wants to alert the SC, ST, and OBC category because t
Leader of Opposition in Lok Sabha and Congress MP Rahul Gandhi has left Hathras after meeting the
Indian cricketer Hardik Pandya is in the news for his personal life. There are reports of turmoil
India got a bronze medal on Tuesday, the fourth day of the Paris Olympics when the pair of Manu B
Amidst the strong demand for complete cancellation of the integrated 70th Combined Preliminary Co
The poster of Ajay Devgan's much-awaited film 'Son of Sardar 2' has been released. In the poster,
The Waqf Amendment Act 2025 is to be heard in the Supreme Court today. The constitutional validit
Shah Rukh Khan has been supporting his son Aryan Khan's luxury brand since the beginning. Recentl
One country-one election bill will be presented in Lok Sabha today, BJP issued a whip to MPs
The Constitution (129th Amendment) Bill for 'One Nation One Election' is going to be introduced i
Doctors are on strike in government hospitals in Delhi today in protest against the murder of a d
